Alzinova AB (ALZ) - Net Assets

Latest as of December 2025: Skr121.96 Million SEK ≈ $13.12 Million USD

Based on the latest financial reports, Alzinova AB (ALZ) has net assets worth Skr121.96 Million SEK (≈ $13.12 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr143.43 Million ≈ $15.44 Million USD) and total liabilities (Skr21.47 Million ≈ $2.31 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ALZ goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr121.96 Million
% of Total Assets	85.03%
Annual Growth Rate	45.31%
5-Year Change	37.85%
10-Year Change	282.32%
Growth Volatility	323.05

Alzinova AB - Net Assets Trend (2012–2025)

This chart illustrates how Alzinova AB's net assets have evolved over time, based on quarterly financial data. See Alzinova AB (ALZ) defensive interval to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Alzinova AB (2012–2025)

The table below shows the annual net assets of Alzinova AB from 2012 to 2025. For live valuation and market cap data, see Alzinova AB market cap and net worth.

Year	Net Assets	Change
2025-12-31	Skr121.96 Million ≈ $13.12 Million	-1.50%
2024-12-31	Skr123.82 Million ≈ $13.33 Million	+8.75%
2023-12-31	Skr113.86 Million ≈ $12.25 Million	+7.89%
2022-12-31	Skr105.53 Million ≈ $11.36 Million	+19.28%
2021-12-31	Skr88.47 Million ≈ $9.52 Million	-7.86%
2020-12-31	Skr96.02 Million ≈ $10.33 Million	+62.45%
2019-12-31	Skr59.11 Million ≈ $6.36 Million	-7.28%
2018-12-31	Skr63.75 Million ≈ $6.86 Million	+116.91%
2017-12-31	Skr29.39 Million ≈ $3.16 Million	-7.86%
2016-12-31	Skr31.90 Million ≈ $3.43 Million	+54.60%
2015-12-31	Skr20.63 Million ≈ $2.22 Million	+1228.93%
2014-12-31	Skr1.55 Million ≈ $167.09K	+114.55%
2013-12-31	Skr723.69K ≈ $77.88K	-23.61%
2012-12-31	Skr947.42K ≈ $101.96K	--

Equity Component Analysis

This analysis shows how different components contribute to Alzinova AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 24927156700.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	Skr27.44 Million	22.50%
Other Comprehensive Income	Skr138.95 Million	113.93%
Other Components	Skr205.46 Million	168.46%
Total Equity	Skr121.96 Million	100.00%

Alzinova AB Competitors by Market Cap

The table below lists competitors of Alzinova AB ranked by their market capitalization.

Company	Market Cap
EXCELLENCE S.A. ZY -10 F:8XY	$8.00 Million
Target Healthcare REIT Ltd LSE:THRL	$8.01 Million
Samyang Corp Preference Shares KO:145995	$8.03 Million
Cambium Bio Ltd AU:CMB	$8.03 Million
Labrador Gold Corp V:LAB	$7.99 Million
DarkIris Inc. Class A Ordinary Shares NASDAQ:DKI	$7.99 Million
Renoworks Software Inc V:RW	$7.99 Million
GCP Infrastructure Investments Limited LSE:GCP	$7.99 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Alzinova AB's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 123,823,000 to 121,961,000, a change of -1,862,000 (-1.5%).
Net loss of 26,266,000 reduced equity.
Share repurchases of 31,097,000 reduced equity.
New share issuances of 31,097,000 increased equity.
Other comprehensive income increased equity by 138,953,000.
Other factors decreased equity by 114,549,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Skr-26.27 Million	-21.54%
Share Repurchases	Skr31.10 Million	-25.5%
Share Issuances	Skr31.10 Million	+25.5%
Other Comprehensive Income	Skr138.95 Million	+113.93%
Other Changes	Skr-114.55 Million	-93.92%
Total Change	Skr-	-1.50%

Book Value vs Market Value Analysis

This analysis compares Alzinova AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.39x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 0.72x to 0.39x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2012-12-31	Skr0.66	Skr0.48	x
2013-12-31	Skr0.51	Skr0.48	x
2014-12-31	Skr0.36	Skr0.48	x
2015-12-31	Skr3.19	Skr0.48	x
2016-12-31	Skr2.91	Skr0.48	x
2017-12-31	Skr3.88	Skr0.48	x
2018-12-31	Skr5.85	Skr0.48	x
2019-12-31	Skr5.33	Skr0.48	x
2020-12-31	Skr5.45	Skr0.48	x
2021-12-31	Skr5.02	Skr0.48	x
2022-12-31	Skr4.33	Skr0.48	x
2023-12-31	Skr2.83	Skr0.48	x
2024-12-31	Skr1.85	Skr0.48	x
2025-12-31	Skr1.21	Skr0.48	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Alzinova AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -21.54%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.00%
• Asset Turnover: 0.00x
• Equity Multiplier: 1.18x
Recent ROE (-21.54%) is above the historical average (-28.88%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2012	-195.83%	-84.72%	1.96x	1.18x	Skr-1.95 Million
2013	-46.39%	-40.00%	0.58x	2.01x	Skr-408.10K
2014	-30.37%	-49.41%	0.45x	1.38x	Skr-626.78K
2015	-16.51%	-341.28%	0.04x	1.08x	Skr-5.47 Million
2016	-9.29%	-56.43%	0.16x	1.04x	Skr-6.15 Million
2017	-8.53%	-43.31%	0.18x	1.08x	Skr-5.45 Million
2018	-6.57%	-44.76%	0.14x	1.04x	Skr-10.56 Million
2019	-10.49%	-91.09%	0.11x	1.07x	Skr-12.11 Million
2020	-6.77%	-43.63%	0.15x	1.05x	Skr-16.10 Million
2021	-8.57%	-43.79%	0.19x	1.04x	Skr-16.43 Million
2022	-12.38%	-78.58%	0.15x	1.06x	Skr-23.62 Million
2023	-14.47%	-6103.70%	0.00x	1.08x	Skr-27.87 Million
2024	-16.60%	-68510.00%	0.00x	1.08x	Skr-32.94 Million
2025	-21.54%	0.00%	0.00x	1.18x	Skr-38.46 Million

Industry Comparison

This section compares Alzinova AB's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $165,146,942
Average return on equity (ROE) among peers: -27.89%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Alzinova AB (ALZ)	Skr121.96 Million	-195.83%	0.18x	$8.00 Million
2cureX AB (2CUREX)	$74.34 Million	-25.47%	0.06x	$5.16 Million
Ascelia Pharma AB (publ) (ACE)	$237.06 Million	-16.83%	0.06x	$41.03 Million
AcouSort AB (ACOU)	$376.48K	28.69%	1.44x	$9.52 Million
Active Biotech AB (ACTI)	$46.67 Million	-106.88%	0.22x	$103.60 Million
AlzeCure Pharma (ALZCUR)	$233.17 Million	-15.43%	0.02x	$46.62 Million
Annexin Pharmaceuticals AB (ANNX)	$15.57 Million	-63.12%	0.51x	$9.23 Million
Alligator Bioscience AB (ATORX)	$41.44 Million	0.00%	0.15x	$11.36 Million
BioInvent International AB (BINV)	$49.01 Million	-36.81%	0.66x	$163.58 Million
BioArctic AB (publ) (BIOA-B)	$788.68 Million	-15.19%	0.14x	$2.39 Billion

About Alzinova AB

ST:ALZ Sweden Biotechnology

Market Cap

$8.00 Million

Skr74.30 Million SEK

Market Cap Rank

#27570 Global

#612 in Sweden

Share Price

Skr0.48

Change (1 day)

-0.10%

52-Week Range

Skr0.40 - Skr2.03

All Time High

Skr26.90